Iparomilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iparomilimab, covering 2025-04-04 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer [Phase 2, Phase 3]